Interventional studies for polycystic ovarian syndrome in children and adolescents. - Wikidata - awgldk - TriplyDB

Interventional studies for polycystic ovarian syndrome in children and adolescents.

Interventional studies for polycystic ovarian syndrome in children and adolescents.

http://www.wikidata.org/entity/Q33996662

about

Features of Polycystic Ovary Syndrome in adolescence Myo-Inositol in the Treatment of Teenagers Affected by PCOS.Association between circulating adiponectin levels and polycystic ovarian syndrome.

P2860

Q26782435-706A81EC-4EDC-469E-A3E3-6D8418D4B50C Q37222857-D008E244-0B6F-4ABB-BBA9-CFC8DEA56D89 Q37591691-BCA114D1-5182-4B1C-ACDD-72F332B65200

P2860

Interventional studies for polycystic ovarian syndrome in children and adolescents.

http://www.wikidata.org/entity/Q33996662

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Interventional studies for polycystic ovarian syndrome in children and adolescents.

@ast

Interventional studies for polycystic ovarian syndrome in children and adolescents.

@en

type

label

Interventional studies for polycystic ovarian syndrome in children and adolescents.

@ast

Interventional studies for polycystic ovarian syndrome in children and adolescents.

@en

prefLabel

Interventional studies for polycystic ovarian syndrome in children and adolescents.

@ast

Interventional studies for polycystic ovarian syndrome in children and adolescents.

@en

P1433

Q33996662-2311FBEF-9854-4CB4-981A-476006437B97

P1476

Q33996662-9125075E-D493-4F9C-B22F-EA48C0461171

P2093

Q33996662-AA23CFAB-E8B0-4E5B-AFD2-E7D926C1AF3A

P2860

Q33996662-0087ABC7-9B3A-49B1-A3EB-710ABDF8D6FB

Q33996662-06D73926-E2C1-4901-969A-75C7ED056943

Q33996662-090BC474-45FA-4938-AABC-B5EECE91E58E

Q33996662-0B7C7467-3A64-43DD-B3EC-C3F0C14A4093

Q33996662-0BA6B81C-99E2-4491-B9C8-02186FE35FE4

Q33996662-0C01DDA9-7096-4D22-9AF7-1F3DEF45ACCC

Q33996662-0C4A6B48-657C-4C8B-95B7-4EC811CF5012

Q33996662-0CAFD9FB-1701-45FA-8F30-C46B2CA013B2

Q33996662-0E673F85-1607-4E16-ACEF-007E92812856

Q33996662-158CFC8E-0993-47D7-ADF2-39ACFDE4CC00

P304

Q33996662-6DB73722-3D83-4A67-AA03-B9EB3F6F2EE7

P31

Q33996662-1D5084F0-7C39-467E-87AF-1E8B58169668

P356

Q33996662-50D7371C-6C66-468E-9D1F-5541B8424F90

P433

Q33996662-A70A093A-DD04-4610-B174-DD68D925D1D7

P478

Q33996662-F0DCF69F-0B93-45EB-94C6-BBC00B9BD335

P50

Q33996662-1B8C610F-E278-4154-978A-31EC6E2268F5

P577

Q33996662-CA87F6E2-2A83-4AE2-AB87-23D9B0EAEEAD

P5875

Q33996662-88D6E8EB-55B0-422A-861F-4D24FFB699DC

P698

Q33996662-E2FBE05C-E614-4159-B866-4C43C6B44779

P932

Q33996662-BE1F7BF3-9025-4AE8-B005-A793F6E60411

P356

P1433

Pediatric health

P1476

Interventional studies for polycystic ovarian syndrome in children and adolescents

@en

P2093

Patricia Myriam Vuguin

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls--implications for regulation of pubertal maturation.

The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.

Polycystic ovary syndrome in adolescence.

The evaluation and management of hirsutism.

P304

59-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PHE.09.69

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Patricia M Vuguin

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45272589

http://www.w3.org/2001/XMLSchema#string

P698

20640230

http://www.w3.org/2001/XMLSchema#string

P932

2904463

http://www.w3.org/2001/XMLSchema#string